Mt. Jackson, VA – October 1, 2024: StageBio Senior Director of Medical Device & Neuropathy Sarah Cramer, DVM, PhD, DACVP, will co-present a Continuing Education course at the American College of Toxicology (ACT) 45th Annual Meeting in Austin, Texas.
The StageBio Team will be hosting booth #416 and will be ready to connect in between meetings and presentations.
ACT 2024 will take place from November 17 to November 20 and facilitate an exchange of information and perspectives between professionals in pharma and biotech, regulatory agencies, contract research organizations, academia, and consulting firms regarding safety assessment and novel approaches in applied toxicological sciences.
The annual meeting will feature an extensive scientific program consisting of a variety of educational courses, symposia, and workshops.
Dr. Cramer’s continuing education course, titled Toxicologic Neuropathy of Novel Therapeutics, will be held on November 17 from 1:00 PM to 4:30 PM Central. Along with her co-speakers, Cramer will present an overview of the mechanisms of action, toxicologic liabilities, and safety risk assessment approaches for novel biotherapeutics being developed for the treating of nervous system disorders and neuromuscular diseases.
Attend Sarah Cramer’s course for insights into this exciting topic. She and other StageBio team members will also be available to connect with visitors for the duration of the meeting. Stop by their booth #416 in between sessions. For more information regarding the preclinical and clinical capabilities services of StageBio, contact our team.
About StageBio
StageBio is a leading provider of GLP-compliant necropsy, histology, pathology and specimen archiving services for the biopharmaceutical, medical device, academic, government and contract research industries. The company operates three GLP laboratories as well as two GLP specimen archiving facilities in the U.S. and Europe, with substantial continued investment in facility and technology infrastructure to meet the growing demand for high-quality histopathology services globally. StageBio has a team of 25 board-certified veterinary pathologists and more than 100 scientific personnel on staff supporting our unified commitment to quality, scientific integrity and client satisfaction. Learn more at www.stagebio.com.